• About
  • Subscribe
  • Advertise
  • Contact
Friday, May 23, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Now is the time for Optometry Australia to be transparent

by Staff Writer
October 22, 2019
in News
Reading Time: 7 mins read
A A
Share on FacebookShare on Twitter

Led by CEO Ms Lyn Brodie, the organisation claims to advance, engage, unite and promote optometry. Recently some of its decisions have barrassed both itself and the profession.In February, a routine question from an Insight journalist regarding OA’s current mbership number received a response of: “That’s confidential”.Believing there must be a misunderstanding and that no Australian not-for-profit organisation would keep this information confidential, we sought to clarify the issue. Brodie subsequently told Insight that OA’s number is not a secret. So, again, we asked for the number.What followed reads like a scene from Yes, Prime Minister:

  • “No, our mbership number is not confidential, or a secret.”
  • “Ok, can you give us the number?”
  • “No, we won’t!”

We were given a number of reasons why it would not be supplied, including the extraordinary comment that mbership numbers are “meaningless”. But through all the obfuscation, it rains true that while 14 other similar not-for-profit health-related bodies were more than happy to provide their current mbership number, OA was the only one that would not.Any sensible reader would ask, “Why?”They might also understand that when you tell the media something is “confidential” they become intrigued. Even more obvious is that once you tell the media that something is “not confidential” and then continue to keep it a secret, they become even more determined to shine a light on the issue.After several bewildering statents from Brodie, such as “even our mbers would find a number meaningless,” OA president Darrell Baker entered the fray.Baker had two choices: to realise the absurdity of the situation, declare the number and bring an end to the issue, or continue to maintain confidentiality in an attpt to avoid further barrassment for Brodie.The astute choice would have been the former: behave just like 14 other professional bodies and put your mbership number on the public record, which OA had done several years ago before switching to a percentage estimate.After Baker chose the latter, his next steps did not achieve the outcome he expected.When asked directly if OA would provide the number at a mber’s request, rather than answer “Yes”, Baker lodged a complaint with the Media, Entertainment and Arts Alliance (MEAA).He attpted to portray Insight’s investigation as intimidating, aggressive and unfair. Baker either believed or was mistakenly advised that a complaint would put an end to the matter and end the scrutiny of OA’s obscure managent practice.This misstep proved to lead nowhere.As reported last week, the MEAA’s National Ethics Committee unanimously dismissed Baker’s complaint. “The panel is of the view that … correspondence with Optometry Australia officers is professional and not aggressive or intimidating,” the ruling reads.A peak industry body resorting to such tactics barrasses the profession it purports to represent. Why, why, why?OA appears to have spent considerably more time and effort not giving a number and dealing with the fallout than it otherwise would have if it were more transparent. This raises the question: why would OA go to such lengths to not reveal its mbership figures?One obvious answer is that the figures are not positive. At least one OA branch is already on the record as stating its mbership, as a percentage of total registered optometrists, is dropping. While OA claims its mbership figure is 82.5% of optometrists registered with the Optometry Board Of Australia (OBA), no evidence has been shown to support it. It’s simple: if the estimate is accurate, why not just place the actual figure on the public record?If Baker will not do that, it leads to suspicion that Brodie’s 82.5% claim is not accurate.If OA’s actual mbership is significantly lower, perhaps around 70%-75% – as a number of people with knowledge of the matter have suggested – an estimate might be preferable to reality.There’s a hint of this in Baker’s complaint to the MEAA. He claimed that information supplied to Insight in March “accurately reflects our mbership” (Insight’s phasis). A ‘reflection’, whether accurate or not, is not the same as the actual mbership tally, something with which the MEAA Ethics Committee agreed.So, what does OA stand to gain by keeping its actual mbership figure confidential, behind a, so-called, ‘accurate reflection’?It could make it more difficult for mbers to hold managent accountable, especially in matters relating to the overall financial health of the organisation or any potential hikes in mbership fees.Responsibility is another issue. By requiring people to calculate a ‘reflection’ of OA’s mbership based off a figure from a third party website, OA cannot be blamed for the publication of any inaccurate figures. Errors and/or exaggeration become the responsibility of the person who calculated the number, rather an OA itself.One wonders how many people have had to undertake this exercise.It also avoids an official number being used as a measure of success for OA’s staff and managent. All this can be easily rectified. As Insight previously pointed out, OA’s annual reports include an exhaustive breakdown of information about the organisation, including its mbership dographics. However there is one, simple, important figure missing: an actual mbership number.The number is clearly known to OA, it just rains off the public record. Why? What is there to hide?We call on the OA board to end this lack of transparency by declaring its mbership figure at the time of its 2018-2019 annual report, placing it on the record for mbers and the wider profession. We also call for it to be published each and every year thereafter.As for Baker’s actions, mbers will have their say in due course.Background reading: Insight responds to OA: the facts

With Brodie, the board now finds itself in a very difficult position. OA is an association that exists for, and is financed by, its mbers. Brodie’s extraordinary statent that mbership numbers are “meaningless” has left many people scratching their heads.As Insight previously documented, a board has certain obligations to its mbers. Further, based on what has transpired, it’s hard to see how OA complies with Principle 7 on Accountability and Transparency of The Not-for-Profit Governance Principles as set out by the Australian Institute of Company Directors.To the Optometry Australia board: you can easily end this barrassment by behaving in the same way as other health-related bodies. It is the very least your mbers deserve. More reading:

OA complaint dismissed: committee rules in favour of Insight
Optometry Australia mbership "confidential"
Optometry Australia holds firm on "confidential" mbership number
Insight responds to Optometry Australia: the facts

Related Posts

CR Labs' ECO7 lens follows the success of its ECO6 product. Image: CR Labs.

CR Labs launches new sustainable lens in thinner format

by Staff Writer
May 22, 2025

CR Labs has launched ECO7, its latest innovation in sustainable lens technology. The company says the new lens builds on...

The Provincial Referral Hospital of Ratanakiri that has received support from Sight For All. Image: Sight For All.

Sight For All raising funds for ophthalmic equipment in new eye clinics   

by Staff Writer
May 22, 2025

Australian not-for-profit Sight For All has teamed up with long-term supporter ZEISS, in a drive to raise funds for much-needed...

Every year, thousands of Australians receive a life-changing diagnosis of low vision. Image: De Visu/Shutterstock.com.

SeeWay launches national support platform for people with low vision

by Staff Writer
May 21, 2025

SeeWay, an initiative of Guide Dogs NSW/ACT, has launched its holistic support platform for people with permanent low vision. A...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited